Effects of a new 1,3,4-thiadiazolium mesoionic compound, MI-D, on the acute inflammatory response

Drug Development Research

Volumn 61, Issue 4, 2004, Pages 207-217

  Cardoso, Júlio C ^a   Cadena, Sílvia M S C ^a   Zampronio, Aleksander ^a   Arruda, Ana Maria S ^a   Carnieri, Eva G S ^a   Echevarria, Aurea ^b   Constantin, Jorgete ^c   Bracht, Adelar ^c   Oliveira, Maria Benigna M ^a  

^a FEDERAL UNIVERSITY OF PARANÁ   (Brazil)

^b FEDERAL RURAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^c STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

Antiinflammatory activity; Cyclooxygenase; Mesoionic 1,3,4 thiadiazolium

Indexed keywords

4 PHENYL 5 (4 NITROCINNAMOYL) 1,3,4 THIADIAZOLIUM 2 PHENYLAMINE; ACETIC ACID; ANTIINFLAMMATORY AGENT; CARRAGEENAN; LIPOPOLYSACCHARIDE; NITRIC OXIDE; NONSTEROID ANTIINFLAMMATORY AGENT; PHORBOL 13 ACETATE 12 MYRISTATE; PROSTAGLANDIN E2; SUPEROXIDE; THIADIAZOLE DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ANTINOCICEPTION; ANTIPYRETIC ACTIVITY; ARTICLE; CEREBROSPINAL FLUID; CONTROLLED STUDY; DRUG MEGADOSE; FEVER; GLYCOGENOLYSIS; GLYCOLYSIS; INFLAMMATION; LIVER METABOLISM; LIVER PERFUSION; MACROPHAGE; MALE; MOUSE; NONHUMAN; OXYGEN CONSUMPTION; PAW EDEMA;

EID: 4944238203     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10354     Document Type: Article

References (45)

1. Bergmeyer Hu, Bernet E. 1974. Glucose determination with glucose oxidase and peroxidase. Methods Enzym Anal 3:1205-1215.
2. Cadena SMSC, Carnieri EG, Echevarria A, Oliveira MBM. 1998. Effect of MI-D, a new mesoionic compound, on energy-linked functions of rat liver mitochondria. FEBS Lett 440:46-50.
3. Cadena SMSC, Carnieri EG, Echevarria A, Oliveira MBM. 2002. Interference of MI-D, a new mesoionic compound, on artificial and native membranes. Cell Biochem Func 20:31-37.
4. 2 receptors in bradykinin-induced rat paw oedema. Br J Pharmacol 114:1005-1013.
5. Cao C, Matsumura K, Yamagata K, Watanabe Y. 1996. Endothelial cells of the rat brain vasculature express cyclooxygenase-2 mRNA in response to systemic interleukin-1β: a possible site of prostaglandin synthesis responsible for fever. Brain Res 733:263-272.
6. Cao C, Matsumura K, Yamagata K, Watanabe Y. 1997. Involvement of cyclooxygenase-2 in LPS-induced fever and regulation of its mRNA by LPS in the rat brain. Am J Physiol 272: R1712-1725.
7. Clissold SP. 1986. Paracetamol and phenacetin. Drugs 32:suppl 4:46-59.
8. Collier HOJ, Dinneen LC, Johnson CA, Schneider C. 1967. The abdominal constriction response and its suppression by analgesic drugs in the mouse. Br J Pharmac Chemother 32:295-310.
9. Corell T, Pedersen SB, Lissau B, Moilanen E, Metsä-Ketelä T, Kankaanranta H, Vuorinen P, Vapaatalo H, Rydell E, Andersson R, Marcinkiewicz E, Korbut R, Gryglewski RJ. 1994. Pharmacology of mesoionic oxatriazole derivatives in blood, cardiovascular and respiratory systems. Pol J Pharm 46:553-566.
10. Czoc R, Lamprecht W. 1974. Pyruvate, phosphoenolpyruvate and D-glycerate-2-phosphate. Methods Enzyymol Anal 3:1446-1451.
11. Fung HB, Kirschenbaum HL. 1999. Selective cyclooxygenase-2 inhibitors for treatment of arthritis. Clin Ther 21:1131-1157.
12. 15nitrates] in biological fluids. Anal Biochem 126:131-138.
13. Grynberg N, Santos AC, Echevarria A, 1997. Synthesis and in vivo antitumor activity of new heterocyclic derivatives of the 1,3,4-thiadiazolium-2- aminide class. Anti-Cancer Drugs 8:88-91.
14. + Methods Enzymol Anal 3:1464-1469.
15. Hanks JH, Wallace RE. 1949. Relation of oxygen and temperature in the preservation of tissues by refrigeration. Proc Soc Exp Biol Med 71:196-200.
16. Hoidal JR, Repine JE, Beall GD, Rasp FLJR, White JG. 1978. The effect of phorbol myristate acetate on the metabolism and ultrastructure of human alveolar macrophages. Am J Pathol 91:469-482.
17. Ikeda Y, Ueno A, Naraba H, Oh-Ishi S. 2001. Involvement of vanilloid receptor VR1 and prostanoids in the acid-induced writhing responses of mice. Life Sci 69:2911-2919.
18. Jacob M, Bjarnason I, Rafi S, Wrigglesworth J, Simpson RJ. 2001. A study of the effects of indomethacin on liver mitochondria from rats, mice and humans. Aliment Pharmacol Ther 15:1837-1842.
19. Jett MF, Ramesha CS, Brown CD, Chiu S, Emmett C, Voronin T, Sun T, O'yang C, Hunter JC, Eglen RM, Johnson RM. 1999. Characterization of the analgesic and anti-inflammatory activities of ketorolac and its enantiomers in the rat. J Pharmacol Exp Ther 288:1288-1297.
20. Johnston RB, Godzik CA, Cohn ZA. 1978. Increased superoxide anion production immunologically activated and chemically elicited macrophages. J Exp Med 148:115-127.
21. Kemmelmeyer FS, Bracht A. 1989. Effects of the nonsteroidal anti-inflammatory drug mefenamic acid on energy metabolism in the perfused rat liver. Biochem Pharmacol 38:823-830.
22. Kiyotaki C, Bloom BR, 1984. Activation of murine macrophage cell lines. Possible involvement of protein kinase in stimulation of superoxide production. J Immunol 133:923-931.
23. Kluger MJ. 1991. Fever: role of pyrogens and cryogens. Physiol Rev 71:93-127.
24. Kurumbail RG, Stevens AM, Gierse JK, Mcdonald JJ, Stegeman RA, Pak JY, Gildehaus D, Miyashiro JM, Penning TD, Seibert K, Isakson PC, Stallings WC. 1996. Structural basis for selective inhibition of cyclooxygenase-2 by anti-inflammatory agents. Nature 384:644-648.
25. Lopez CH, Bracht A, Yamamoto NS, Santos M. 1998. Metabolic effects and distribution space of flufenamic acid in the isolated perfused rat liver. Chem-Biol Interact 116:105-122.
26. Lowry, OH, Rosebrough NJ, Farr AC, Randall R J. 1951. Protein measurement with the Folinphenol reagent. J Biol Chem 193:265-275.
27. Masubuchi Y, Yamada S, Horie, T. 1999. Diphenylamine as an important structure of nonsteroidal anti-inflammatory drugs to uncouple mitochondrial oxidative phosphorylation. Biochem Pharmacol 58:861-865.
28. Masubuchi Y, Yamada S, Horie, T. 2000. Possible mechanism of hepatocyte injury induced by diphenylamine and its structurally related nonsteroidal anti-inflammatory drugs. J Pharmacol Exp Ther 292:982-987.
29. Montanari CA, Amaral AT, Giesbrecht AM. 1997. Synthesis and antibacterial activity of some new 1,3,4-thiadiazolium-2-aminide derivatives. Pharm Sci 3:565-568.
30. Moreland DE. 1994. Effects of toxicants on oxidative phosphorylation and photophosphorylation. In: Hodgson E, Levi PE, editors. Introduction to biochemical toxicology, 2nd ed. Norwalk, Connecticut: Appleton & Lange. p 345-366.
31. Nakamura H, Yokoyama Y, Motoyoshi S, Seto Y, Kadokawa T, Shimizu M. 1985. Inhibition of prostaglandin generation in the rabbit brain in vivo by AD-1590, a non-steroidal anti-inflammatory agent with potent antipyretic activity. J Pharm Pharmacol 37:894-898.
32. Newton CG, Ramsden CA. 1982. Meso-ionic heterocycles. Tetrahedron 38:2965-3011.
33. Nishihata T, Ikawa C, Saitoh Y, Sakai K. 1988. Glycogenolysis in the rat isolated perfused liver as a measure of chemically induced liver toxicity. J Pharm Pharmacol 40:333-336.
34. Petrescu I, Tarba C. 1997. Uncoupling effects of diclofenac and aspirin in the perfused liver and isolated hepatic mitochondria of rat. Biochim Biophys Acta 1318:385-394.
35. Reichert JA, Daughters RS, Rivard R, Simone DA. 2001. Peripheral and preemptive opioid antinociception in a mouse visceral pain model. Pain 89:221-227.
36. Reilly TP, Bellevue FH, Woster PM, Svensson CK. 1998. Comparison of the in vitro cytotoxicity of hydroxylamine metabolites of sulphamethoxazole and dapsone. Biochem Pharmacol 55:803-810.
37. Saini T, Bagchi M, Bagchi D, Jaeger S, Hosoyama S, Stohs SJ. 1998. Protective ability of acetylsalicylic acid (aspirin) to scavenge radiation induced free radicals in J774A 1 macrophage cells. Res Commun Mol Pathol Pharmacol 101:259-268.
38. Sasada M, Pabt MJ, Johnston RB. 1983. Activation of mouse peritoneal macrophages by lipopolysaccharide alters the kinetic parameters of the superoxide-producing NADPH oxidase. J Biol Chem 258:9631-9635.
39. Satyanarayana K, Rao MNA. 1995 Synthesis and antiinflammatory, analgesic and antipyretic testing of 4-[1-oxo (3-substituted aryl)-2-propenyl]-3- phenylsydnones and 3-[4-(3-(substituted aryl)-1-oxo-2-propenyl) phenyl] sydnones. J Pharm Sci 84:263-266.
40. Scholz R, Bücher T. 1965. Hemoglobin-free perfusion of rat liver. In: Chance B, Estabrook RW, Williamson JR, editors. Control of energy metabolism. New York: Academic Press. p. 393-414.
41. Senff-Ribeiro A, Echevarria A, Silva EF, Veiga SS, Oliveira MBM. 2003. Effect of a new mesoionic compound (MI-D) on B16-F10 murine melanoma. Melanoma Res 23:465-472.
42. Senff-Ribeiro A, Echevarria A, Silva EF, Veiga SS, Oliveira MBM. 2004. Antimelanoma activity of 1,3,4-thiadiazolium mesoionics: a structure-activity relationship study. Anticancer Drugs 15:269-275.
43. Vane JR. 1971. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nature 231:232-235.
44. Zampronio AR, Souza GE, Silva CA, Cunha FQ, Ferreira SH. 1994. Interleukin-8 induces fever by a prostagladin-independent mechanism. Am J Physiol 266:1670-1674.
45. Zampronio AR, Hodley ME, Luheshi G, Rothwell NJ, Souza GEP, Hopkins SJ. 2000. Interleukin (IL)-6 release and fever induced by a pre-formed pyrogenic factor (PFPF) derived from LPS-stimulated macrophages. Eur Cytokine Netw 11:589-596.